LIVE

MarketsZachXBT сообщил о взломе европейского финучреждения и краже более $133 млн с криптобирж TechThe Endlessly Meme-able Steve Kornacki Is Not a Meme Person BusinessAMA voices cannabis concerns to federal officials (Newsletter: November 3, 2026)MarketsLouisiana-Pacific beats top-line and bottom-line estimates; gives Q4 and updates FY26 outlook MarketsIDEAYA Biosciences GAAP EPS of -$1.22 misses by $0.03, revenue of $10.24M beats by $2.66M MarketsMichael Burry Boosts Bets on BYD, JD.com, and Sprouts; Retains Fiserv and PayPal - TipRanks MarketsGartner beats top-line and bottom-line estimates; updates FY26 outlook MarketsBall Corporation Non-GAAP EPS of $1.10 beats by $0.03, revenue of $4.19B beats by $410M LocalSullivan lawmakers to hire outside counsel following state supreme court ruling - Mid Hudson News MarketsLeidos beats Q3 earnings estimates, raises FY2026 EPS outlook MarketsDuPont raises 2026 earnings forecast after stronger Q3 performance MarketsPatria Investments DEPS of $0.30 beats by $0.02, revenue of $104.2M beats by $2.46M BusinessPie Medical anuncia los resultados del ensayo LIPSIA-STRATEGY en revascularización BusinessLIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization BusinessDie LIPSIA-STRATEGY-Studie belegt die Nichtunterlegenheit der CAAS-vFFR-gesteuerten Revaskularisierung gegenüber der auf einem Druckdraht basierenden FFR-Revaskularisierung BusinessL'essai LIPSIA-STRATEGY démontre la non-infériorité de la revascularisation guidée par CAAS vFFR par rapport à la revascularisation FFR basée sur le fil de pression.LocalUS Supreme Court to weigh Catholic preschools' challenge to LGBT protections - Reuters BusinessFallsview Arts Marks First Year with Grand Opening Exhibition and Ribbon Cutting BusinessLINC Shareholder Notice: Lincoln Educational Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 10 BusinessQFIN Shareholder Notice: Qfin Holdings Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 27 BusinessENSG Shareholder Notice: Ensign Group Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 7 BusinessFLNC Shareholder Notice: Fluence Energy Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 27 BusinessGIL Shareholder Notice: Gildan Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 14 BusinessFUN Shareholder Notice: Six Flags Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to Investors BusinessPSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of ShareholdersTRENDING TICKERS: $CRWD $NTAP $EL $NIQ $GIL $IQMX $HIMS $ASTS $ROK $LAZ $QBTS $BULL $DUOL $LINC $CC $TMUS $APP $TENX $FLNC $BAC $BBNX $VEEV $LKQ $MRP $LDOS $FE $EG $YFOR $MSTR $FCELMarketsZachXBT сообщил о взломе европейского финучреждения и краже более $133 млн с криптобирж TechThe Endlessly Meme-able Steve Kornacki Is Not a Meme Person BusinessAMA voices cannabis concerns to federal officials (Newsletter: November 3, 2026)MarketsLouisiana-Pacific beats top-line and bottom-line estimates; gives Q4 and updates FY26 outlook MarketsIDEAYA Biosciences GAAP EPS of -$1.22 misses by $0.03, revenue of $10.24M beats by $2.66M MarketsMichael Burry Boosts Bets on BYD, JD.com, and Sprouts; Retains Fiserv and PayPal - TipRanks MarketsGartner beats top-line and bottom-line estimates; updates FY26 outlook MarketsBall Corporation Non-GAAP EPS of $1.10 beats by $0.03, revenue of $4.19B beats by $410M LocalSullivan lawmakers to hire outside counsel following state supreme court ruling - Mid Hudson News MarketsLeidos beats Q3 earnings estimates, raises FY2026 EPS outlook MarketsDuPont raises 2026 earnings forecast after stronger Q3 performance MarketsPatria Investments DEPS of $0.30 beats by $0.02, revenue of $104.2M beats by $2.46M BusinessPie Medical anuncia los resultados del ensayo LIPSIA-STRATEGY en revascularización BusinessLIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization BusinessDie LIPSIA-STRATEGY-Studie belegt die Nichtunterlegenheit der CAAS-vFFR-gesteuerten Revaskularisierung gegenüber der auf einem Druckdraht basierenden FFR-Revaskularisierung BusinessL'essai LIPSIA-STRATEGY démontre la non-infériorité de la revascularisation guidée par CAAS vFFR par rapport à la revascularisation FFR basée sur le fil de pression.LocalUS Supreme Court to weigh Catholic preschools' challenge to LGBT protections - Reuters BusinessFallsview Arts Marks First Year with Grand Opening Exhibition and Ribbon Cutting BusinessLINC Shareholder Notice: Lincoln Educational Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 10 BusinessQFIN Shareholder Notice: Qfin Holdings Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 27 BusinessENSG Shareholder Notice: Ensign Group Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 7 BusinessFLNC Shareholder Notice: Fluence Energy Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is November 27 BusinessGIL Shareholder Notice: Gildan Sued for Securities Fraud over Alleged Misrepresentations to Investors - Class Action Deadline is December 14 BusinessFUN Shareholder Notice: Six Flags Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to Investors BusinessPSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of ShareholdersTRENDING TICKERS: $CRWD $NTAP $EL $NIQ $GIL $IQMX $HIMS $ASTS $ROK $LAZ $QBTS $BULL $DUOL $LINC $CC $TMUS $APP $TENX $FLNC $BAC $BBNX $VEEV $LKQ $MRP $LDOS $FE $EG $YFOR $MSTR $FCEL

Skip to content

Hikvision brings 130 global tech partners to 2026 HikTech Star Tour, spotlighting hands-on experience and co-innovation

Source: PR Newswire M&A · Nov 03, 2026 10:08 UTC

The Quick Take

HANGZHOU, China, Nov. 3, 2026 /PRNewswire/ -- Hikvision has concluded its 2026 HikTech Star Tour, welcoming 130 tech professionals from 56 countries and regions to its Hangzhou headquarters from October 28 to 30. Held under the theme "Your Vision. Your Impact. Your Stage," this year's...

Read the full story at PR Newswire M&A →

Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.

Related

AMA voices cannabis concerns to federal officials (Newsletter: November 3, 2026)

Ted Cruz’s marijuana & voting joke; NH gov & challenger debate cannabis; Police groups oppose MA legalization rollback; Federal registration op-ed Subscribe to…

Marijuana Moment · 6m ago

Pie Medical anuncia los resultados del ensayo LIPSIA-STRATEGY en revascularización

- El ensayo LIPSIA-STRATEGY de Pie Medical demuestra la no inferioridad de la revascularización guiada por CAAS vFFR frente a la revascularización guiada por…

PR Newswire M&A · 13m ago

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers clinical…

PR Newswire M&A · 13m ago

Die LIPSIA-STRATEGY-Studie belegt die Nichtunterlegenheit der CAAS-vFFR-gesteuerten Revaskularisierung gegenüber der auf einem Druckdraht basierenden FFR-Revaskularisierung

Im Rahmen der LIPSIA-STRATEGY-Studie wurde untersucht, ob eine Revaskularisierung, die anhand der angiographischen FFR unter Verwendung von CAAS-vFFR (vessel…

PR Newswire M&A · 13m ago